TWO SIGMA ADVISERS, LP - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 100 filers reported holding G1 THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 17.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$313,056
+50.7%
217,400
+160.7%
0.00%0.0%
Q2 2023$207,666
-71.7%
83,400
-69.6%
0.00%
-50.0%
Q1 2023$734,856
-57.7%
274,200
-14.3%
0.00%
-60.0%
Q4 2022$1,736,514
+426.2%
319,800
+1111.4%
0.01%
+400.0%
Q3 2022$330,000
+108.9%
26,400
-17.5%
0.00%
Q2 2022$158,000
-74.7%
32,000
-61.1%
0.00%
-100.0%
Q1 2022$625,000
-73.3%
82,200
-64.1%
0.00%
-66.7%
Q4 2021$2,337,000
-48.6%
228,916
-32.4%
0.01%
-50.0%
Q3 2021$4,546,000
-61.8%
338,716
-37.6%
0.01%
-61.3%
Q2 2021$11,912,000
-19.5%
542,916
-11.7%
0.03%
-24.4%
Q1 2021$14,795,000
+71.4%
614,916
+28.2%
0.04%
+78.3%
Q4 2020$8,632,000
+582.9%
479,816
+338.5%
0.02%
+475.0%
Q3 2020$1,264,000
-54.6%
109,416
-4.7%
0.00%
-50.0%
Q2 2020$2,785,000
+137.0%
114,816
+7.7%
0.01%
+100.0%
Q1 2020$1,175,000
-24.9%
106,616
+80.0%
0.00%0.0%
Q4 2019$1,565,000
+279.9%
59,216
+227.2%
0.00%
+300.0%
Q3 2019$412,000
-52.9%
18,100
-36.5%
0.00%
-50.0%
Q2 2019$874,000
+64.0%
28,500
-11.2%
0.00%
+100.0%
Q1 2019$533,000
-3.6%
32,100
+11.1%
0.00%
-50.0%
Q4 2018$553,000
-60.8%
28,900
+7.0%
0.00%
-33.3%
Q3 2018$1,412,000
+128.8%
27,000
+90.1%
0.00%
+50.0%
Q2 2018$617,00014,2000.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
MPM BioImpact LLC 1,423,794$34,541,0009.18%
Burrage Capital Management LLC 373,876$9,070,0006.35%
Birchview Capital, LP 40,000$970,0000.59%
361 CAPITAL LLC 47,325$1,148,0000.54%
Rhenman & Partners Asset Management AB 190,000$4,609,0000.50%
CHI Advisors LLC 44,000$1,067,0000.42%
Bellevue Group AG 721,925$17,514,0000.25%
Candriam S.C.A. 870,423$21,117,0000.22%
Virtus ETF Advisers LLC 18,991$461,0000.22%
HHLR ADVISORS, LTD. 949,431$23,033,0000.21%
View complete list of G1 THERAPEUTICS INC shareholders